Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Johnson and Johnson
Moodys
Baxter
Merck

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021998

See Plans and Pricing

« Back to Dashboard

NDA 021998 describes PLAN B ONE-STEP, which is a drug marketed by Fdn Consumer and is included in one NDA. It is available from four suppliers. Additional details are available on the PLAN B ONE-STEP profile page.

The generic ingredient in PLAN B ONE-STEP is levonorgestrel. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 021998
Tradename:PLAN B ONE-STEP
Applicant:Fdn Consumer
Ingredient:levonorgestrel
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021998
Suppliers and Packaging for NDA: 021998
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PLAN B ONE-STEP levonorgestrel TABLET;ORAL 021998 NDA A-S Medication Solutions 50090-1141 50090-1141-0 1 BLISTER PACK in 1 BOX, UNIT-DOSE (50090-1141-0) > 1 TABLET in 1 BLISTER PACK
PLAN B ONE-STEP levonorgestrel TABLET;ORAL 021998 NDA A-S Medication Solutions 50090-3830 50090-3830-0 1 BLISTER PACK in 1 BOX, UNIT-DOSE (50090-3830-0) > 1 TABLET in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Jul 10, 2009TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Harvard Business School
Colorcon
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.